Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05419830 · ClinicalTrials.gov registry record · NA

Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT05419830 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05419830, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

In this study the investigators target three common and comorbid illnesses among older adults namely nocturia or waking at night to void, poor sleep and hypertension. The aim of this proposal is to test behavioral sleep intervention to improve sleep and nocturia vs switching the time of antihypertensive administration to improve nighttime and in turn daytime blood pressure control.

Interventions

  • BEHAVIORAL BBTI
  • OTHER PM antihypertensive dosing or Chronotherapy
  • OTHER AM antihypertensive dosing

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-06-01
Est. Completion 2024-01-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05419830

The ClinicalTrials.gov registry entry for NCT05419830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which BBTI is the first listed.

NCT05419830 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05419830 about?

NCT05419830 is a clinical study titled "Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses". In this study the investigators target three common and comorbid illnesses among older adults namely nocturia or waking at night to void, poor sleep and hypertension. The aim of this proposal is to test behavioral sleep intervention to improve sleep and nocturia vs switching the time of antihyperten...

What is the current status of trial NCT05419830?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-06-01. Estimated completion is 2024-01-30.

What interventions are being tested in trial NCT05419830?

The interventions under investigation include: BBTI (BEHAVIORAL), PM antihypertensive dosing or Chronotherapy (OTHER), AM antihypertensive dosing (OTHER).

Who is sponsoring clinical trial NCT05419830?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.